Bausch Health Companies | SCHULD



Debt Veränderung Datum
Amgen USD 60.1B 299M 2024-12
ANI Pharmaceuticals USD 624.09M 304.02M 2024-12
Aurora Cannabis CAD 100.98M 11K 2024-12
Bausch Health Companies USD 21.51B 153M 2024-09
Biogen USD 6.3B 1.9M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Danaher USD 16.01B 1.52B 2024-12
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
Novo Nordisk 56.97B 88M 2024-09
Pacira USD 585.32M 2.04M 2024-12
Perrigo USD 3.62B 1.14B 2024-12
Prestige Brands USD 996.95M 54.86M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zoetis USD 6.57B 4M 2024-12



Bausch Health Companies SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.